These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15761943)

  • 21. Concomitant intake of alcohol may increase the absorption of poorly soluble drugs.
    Fagerberg JH; Sjögren E; Bergström CAS
    Eur J Pharm Sci; 2015 Jan; 67():12-20. PubMed ID: 25444841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of an In Vitro Dissolution/Permeation System to Early Screening of Oral Formulations of Poorly Soluble, Weakly Basic Drugs Containing an Acidic pH-Modifier.
    Mizoguchi M; Kataoka M; Yokoyama K; Aihara R; Wada K; Yamashita S
    J Pharm Sci; 2018 Sep; 107(9):2404-2410. PubMed ID: 29802932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Precipitation in the small intestine may play a more important role in the in vivo performance of poorly soluble weak bases in the fasted state: case example nelfinavir.
    Shono Y; Jantratid E; Dressman JB
    Eur J Pharm Biopharm; 2011 Oct; 79(2):349-56. PubMed ID: 21527341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Seed Particles on Precipitation of Weak Base Drugs in Physiological Intestinal Conditions.
    Koyama H; Ito M; Terada K; Sugano K
    Mol Pharm; 2016 Aug; 13(8):2711-7. PubMed ID: 27341490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cinnarizine food-effects in beagle dogs can be avoided by administration in a Self Nano Emulsifying Drug Delivery System (SNEDDS).
    Christiansen ML; Holm R; Kristensen J; Kreilgaard M; Jacobsen J; Abrahamsson B; Müllertz A
    Eur J Pharm Sci; 2014 Jun; 57():164-72. PubMed ID: 24239996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A differential equation based modelling approach to predict supersaturation and in vivo absorption from in vitro dissolution-absorption system (idas2) data.
    Li J; Spivey N; Silchenko S; Gonzalez-Alvarez I; Bermejo M; Hidalgo IJ
    Eur J Pharm Biopharm; 2021 Aug; 165():1-12. PubMed ID: 33971275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Combined In-Vitro and GastroPlus® Modeling to Study the Effect of Intestinal Precipitation on Cinnarizine Plasma Profile in a Fasted State.
    Kesharwani SS; Ibrahim F
    AAPS PharmSciTech; 2023 May; 24(5):121. PubMed ID: 37173520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding the Oral Absorption of Irbesartan Using Biorelevant Dissolution Testing and PBPK Modeling.
    Kaur N; Thakur PS; Shete G; Gangwal R; Sangamwar AT; Bansal AK
    AAPS PharmSciTech; 2020 Mar; 21(3):102. PubMed ID: 32152915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intestinal bile secretion promotes drug absorption from lipid colloidal phases via induction of supersaturation.
    Yeap YY; Trevaskis NL; Quach T; Tso P; Charman WN; Porter CJ
    Mol Pharm; 2013 May; 10(5):1874-89. PubMed ID: 23480483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach.
    Fei Y; Kostewicz ES; Sheu MT; Dressman JB
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1274-84. PubMed ID: 23500116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Precipitation of a poorly soluble model drug during in vitro lipolysis: characterization and dissolution of the precipitate.
    Sassene PJ; Knopp MM; Hesselkilde JZ; Koradia V; Larsen A; Rades T; Müllertz A
    J Pharm Sci; 2010 Dec; 99(12):4982-91. PubMed ID: 20574997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fed and fasted state gastro-intestinal in vitro lipolysis: In vitro in vivo relations of a conventional tablet, a SNEDDS and a solidified SNEDDS.
    Christophersen PC; Christiansen ML; Holm R; Kristensen J; Jacobsen J; Abrahamsson B; Müllertz A
    Eur J Pharm Sci; 2014 Jun; 57():232-9. PubMed ID: 24056027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of food intake on the oral absorption of poorly water-soluble drugs: in vitro assessment of drug dissolution and permeation assay system.
    Kataoka M; Masaoka Y; Sakuma S; Yamashita S
    J Pharm Sci; 2006 Sep; 95(9):2051-61. PubMed ID: 16850428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a Unified Dissolution and Precipitation Model and Its Use for the Prediction of Oral Drug Absorption.
    Jakubiak P; Wagner B; Grimm HP; Petrig-Schaffland J; Schuler F; Alvarez-Sánchez R
    Mol Pharm; 2016 Feb; 13(2):586-98. PubMed ID: 26674605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative analysis of the effect of supersaturation on in vivo drug absorption.
    Takano R; Takata N; Saito R; Furumoto K; Higo S; Hayashi Y; Machida M; Aso Y; Yamashita S
    Mol Pharm; 2010 Oct; 7(5):1431-40. PubMed ID: 20704264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of food effects on the absorption of celecoxib based on biorelevant dissolution testing coupled with physiologically based pharmacokinetic modeling.
    Shono Y; Jantratid E; Janssen N; Kesisoglou F; Mao Y; Vertzoni M; Reppas C; Dressman JB
    Eur J Pharm Biopharm; 2009 Sep; 73(1):107-14. PubMed ID: 19465123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissolution/permeation with PermeaLoop™: Experience and IVIVC exemplified by dipyridamole enabling formulations.
    Eriksen JB; Messerschmid R; Andersen ML; Wada K; Bauer-Brandl A; Brandl M
    Eur J Pharm Sci; 2020 Nov; 154():105532. PubMed ID: 32871215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of a three compartment in vitro gastrointestinal simulator dissolution apparatus to predict in vivo dissolution.
    Takeuchi S; Tsume Y; Amidon GE; Amidon GL
    J Pharm Sci; 2014 Nov; 103(11):3416-3422. PubMed ID: 25251982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new system for the prediction of drug absorption using a pH-controlled Caco-2 model: evaluation of pH-dependent soluble drug absorption and pH-related changes in absorption.
    He X; Kadomura S; Takekuma Y; Sugawara M; Miyazaki K
    J Pharm Sci; 2004 Jan; 93(1):71-7. PubMed ID: 14648637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biorelevant dissolution media as a predictive tool for glyburide a class II drug.
    Wei H; Löbenberg R
    Eur J Pharm Sci; 2006 Sep; 29(1):45-52. PubMed ID: 16815694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.